Results 171 to 180 of about 282,173 (256)

Unveiling a Novel Glioblastoma Deep Molecular Profiling: Insight into the Cancer Cell Differentiation-Related Mechanisms. [PDF]

ACS Omega
Zhou W, Ruan H, Zhu L, Chen S, Yang M.
europepmc   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

Exploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu, Junya Feng, Jie Ma, Tixian Xiao, Wei Yuan   +4 more
wiley   +1 more source

Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone. [PDF]

J Bone Oncol
Yao Y, Lee VKM, Chen ES.
europepmc   +1 more source

Role of lysine lactylation in neoplastic and inflammatory pulmonary diseases (Review). [PDF]

Int J Mol Med
Wang S, Zheng H, Zhao J, Xie J.
europepmc   +1 more source

Emerging Technologies for Timely Point‐of‐Care Diagnostics of Skin Cancer

Global Challenges, EarlyView.
With the global incidence of skin cancer on the rise and a persistent lack of rapid, noninvasive and sensitive point‐of‐care diagnostic platforms, current and emerging technologies are critically reviewed. Among these, the emerging Raman spectroscopy system is identified as a promising complementary to conventional costly and invasive methods, offering
Jarrod L. Thomas, Adrian H. M. Heagerty, Pola Goldberg Oppenheimer   +2 more
wiley   +1 more source

<i>CD44</i> Methylation Levels in Androgen-Deprived Prostate Cancer: A Putative Epigenetic Modulator of Tumor Progression. [PDF]

Int J Mol Sci
Valentini V, Santi R, Silvestri V, Saieva C, Roviello G, Amorosi A, Compérat E, Ottini L, Nesi G.   +8 more
europepmc   +1 more source

The Impact of the Rs1044457 Polymorphism in the CMPK1 Gene on the Response Rate to Gemcitabine‐Based Chemotherapy in Metastatic NSCLC Patients

Advanced Genetics, EarlyView.
Lung cancer is the leading cause of cancer‐related mortality worldwide. Among its types, non‐small cell lung cancer (NSCLC) accounts for the majority of cases. This study focuses on investigating genetic mutations that may influence the response to gemcitabine, a chemotherapy drug commonly used to treat this condition.
Ghassan Saod Saleh, Fouad Kadhim Gatea, Qasim Sharhan Al‐Mayah, Hayder Lazim   +3 more
wiley   +1 more source

Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets? [PDF]

Explor Target Antitumor Ther
Shah A.
europepmc   +1 more source

On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck

Head &Neck, EarlyView.
ABSTRACT Background Infantile fibrosarcoma (IFS) is a rare pediatric tumor of intermediate malignancy with high local aggressiveness that typically presents in young infants. Its occurrence in the head and neck region is rare. Complete non‐mutilating surgical resection is often not possible, requiring multimodal treatment.
Teresa M. Cardesa‐Salzmann, Monika Sparber‐Sauer, Peter Hingst, Andreas Erbersdobler, Bjoern Schneider, Maja Hühns, Andre Jakob, Friederike Terpe, Christian Spang, Dorothea Stalmann, Claudia Bierwirth, Christina Hauenstein, Stefanie Märzheuser, Manfred Ballmann, Carl Friedrich Classen   +14 more
wiley   +1 more source

Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. [PDF]

J Immunother Cancer
Zhang P, Wang D, Zhou G, Jiang S, Zhang G, Zhang L, Zhang Z.   +6 more
europepmc   +1 more source